ORLANDO, Florida — Achieving target glucose and lipid levels reduces the risk for diabetic retinopathy (DR) and other adverse health outcomes in people with diabetes, but...
ORLANDO, Fla. — Patients with type 1 and 2 diabetes who delay treatment with recommended statin therapy to address the well-known high risk for cardiovascular (CV)...
ORLANDO, FL — Continuous glucose monitoring (CGM) of hospitalized patients with diabetes could provide early and important clues about changing insulin needs and reduce the need...
TOPLINE: In adults with type 1 diabetes (T1D), both management- and emotion-focused virtual group programs can lead to a clinically meaningful reduction in diabetes distress (DD)...
The global prevalence of type 1 diabetes (T1D) in people 65 years of age and older increased between 1990 and 2019, while mortality rates associated with...